Zirka

Ukraine
Brand name Zirka
Form balm
Active substance / Dosage
menthol · 41 mg
camphor · 258 mg
clove oil · 9 mg
Prescription type over-the-counter (OTC)
ATC code
Registration number UA/7031/01/01
Zirka balm

INSTRUCTION FOR MEDICAL USE OF THE MEDICINAL PRODUCT Zirka

Composition:

Active substances: menthol, camphor, peppermint oil, eucalyptus oil, clove oil, cinnamon oil;

1 g of balm contains 41 mg of menthol, 258 mg of camphor, 125 mg of peppermint oil, 88 mg of eucalyptus oil, 9 mg of clove oil, 14 mg of cinnamon oil;

Excipients: beeswax, paraffin, lanolin, white soft paraffin, methyl orange.

Pharmaceutical form. Balm.

Main physicochemical properties: balm of plastic consistency, from light-yellow to brown-yellow in color, with the odor of essential oils.

Pharmacotherapeutic group. Antipruritic agents. ATC code D04A X.

Pharmacological properties.

The product belongs to the group of agents that stimulate the receptors of mucous membranes, skin, and subcutaneous tissues. The balm has anti-inflammatory, local warming, antiseptic, and anesthetic properties; it also dilates capillaries, improving blood supply and slightly reducing arterial pressure. It acts on reflex centers of the central nervous system, producing a stimulating effect. The action of the Zvezda balm is manifested by alleviating the inflammatory process and reflex elimination of pain sensations (headache, muscle pain) caused by influenza, colds, diseases of the musculoskeletal system, skin injuries, and other factors.

Clinical characteristics.

Indications.

Symptomatic treatment of dizziness, headache, cold, rhinitis, nausea; in case of insect bites.

Contraindications.

Hypersensitivity to any component of the medicinal product. Bronchial asthma, pertussis, pseudocroup, tendency to bronchospasm or seizures. Skin damage, including burns, impaired skin integrity, eczema, dermatitis, and skin infections with pustules.

Interaction with other medicinal products and other forms of interaction.

Studies on the interaction of the drug with other medicinal products have not been conducted.

Special precautions for use.

For external use only. Avoid contact of the balm with eyes, mucous membranes, and open wounds. Do not insert into nostrils. In individual cases, allergic reactions are possible. If such reactions occur, discontinue use of the medicinal product and wash off any residue from the application sites with warm water and soap.

Use during pregnancy or breastfeeding.

Due to the lack of experience with the use of Star balm during pregnancy or breastfeeding, administration of the drug to these patient groups is not recommended.

Ability to affect reaction speed when driving or operating machinery.

If adverse reactions affecting the nervous system (dizziness, excitement, convulsions) occur, refrain from driving or operating machinery.

Method of Administration and Dosage.

Apply a small amount of the balm to affected areas and rub into the skin: for headache – to the temples and back of the head; for nasal congestion – under the nostrils; for colds – to the chest, back, and abdomen; for insect bites – directly to the site of the bite.

The duration of treatment depends on individual patient characteristics, the course of the disease, and is determined by the therapeutic effect achieved, the nature of concomitant therapy, and the drug's tolerability.

Children.

Contraindicated in children under 3 years of age.

The product should be used with caution in children aged 3 years and older when applied to the facial area, as it may cause bronchospasm.

Overdose.

Possible intensification of adverse reactions, sensation of strong warmth and burning.

In case of accidental ingestion, possible symptoms include abdominal pain, nausea, vomiting, diarrhea, signs of central nervous system depression, dizziness, ataxia, seizures, hot flushes, drowsiness, and respiratory difficulty.

Treatment: wash off the applied product with soap and water. Perform gastric lavage and provide symptomatic therapy.

Side effects.

Allergic reactions, including skin rashes, urticaria, itching, irritation of the skin and mucous membranes, redness, dermatitis, including contact dermatitis, especially in children.

Central nervous system: headache, dizziness, excitement; seizures possibly caused by camphor may occur.

Respiratory system: increased likelihood and frequency of bronchospasm, especially in children.

Shelf life. 5 years.

Storage conditions.

Store in a dry, protected from light place at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging.

4 g per jar; 1 jar in a cardboard box.

Availability. Over-the-counter (without prescription).

Manufacturer.

Danafa Pharmaceutical Joint Stock Company.

Manufacturer's address and location of business activity.

253 Zung Si Thanh The Street, Danang City, Vietnam